Tolera Therapeutics closes Series B-3 financing, raises $5.5 million to submit ... MarketWatch (press release) Tolera Therapeutics closes Series B-3 financing, raises $5.5 million to submit Phase 3 Special Protocol Assessment for its immune targeting biologic drug in kidney transplantation. KALAMAZOO, Mich., Oct. 16, 2012 /PRNewswire via COMTEX/ -- Tolera ... |
